Worldwide Clinical Trials Receives 2020 CRO Leadership Awards for Outstanding Capabilities, Compatibility, Expertise, Quality and Reliability

Contract research organization recognized as a top outsourcing partner for seventh consecutive year by Life Science Leader and Industry Standard Research

MORRISVILLE, N.C.–(BUSINESS WIRE)–Worldwide Clinical Trials, Inc., (Worldwide) a full-service, midsize, global contract research organization (CRO), today announced that it was honored with five 2020 CRO Leadership Awards, presented by Life Science Leader and Industry Standard Research (ISR). This is the seventh consecutive year that the company has been recognized as an exemplary performer across the key categories of Capability, Compatibility, Expertise, Quality and Reliability.

This announcement comes on Clinical Trials Day, which aims to raise awareness of clinical trials and honor professionals who work to improve the lives of individuals around the world. Although randomized clinical trials can be traced back to this day in 1747, today, the research and development of new vaccines, therapeutics and technologies has accelerated to unprecedented rates. The COVID-19 pandemic has reinforced the imperative for industry collaboration, innovative solutions and partner CROs that can quickly pivot to match changing needs.

Understanding the importance of these partnerships, Life Science Leader’s CRO Leadership Awards recognize top CROs based on direct feedback from decision-makers at pharmaceutical companies that have outsourced projects over the last 18 months. Award selection is based on primary market research conducted by ISR for the CRO Quality Benchmarking program, which evaluated 60 CROs across more than 20 performance metrics in six categories. Worldwide achieved top marks from its sponsor customers in the following categories:

• Expertise (Overall, Small Pharma)
• Capabilities (Overall, Small Pharma)
• Compatibility (Overall, Small Pharma)
• Quality (Small Pharma)
• Reliability (Overall, Small Pharma)

“The clinical research industry is proving its value and its mettle as we seek treatments and vaccines that will neutralize COVID-19, while at the same time maintaining an active clinical research program in other debilitating diseases,” said Peter Benton, president and chief operating officer, Worldwide Clinical Trials. “As we celebrate Clinical Trials Day, I can’t think of a better time to reflect on this moment and commend our team for their work to bring critical treatments to market. The CRO Leadership Awards reflect our customers’ appreciation for their tenacity and steadfast approach, and I could not be prouder of their recognition.”

“When talking to clinical operations executives, I’m told the CRO selection process can be one of their most stressful and time-consuming chores,” says Ed Miseta, chief editor, Clinical Leader. “Anything we can do to help steer our readers to those partners that best meet their needs can significantly reduce the burden of their search. That is why we are once again proud to partner with Industry Standard Research to produce our annual CRO Leadership Awards. The organizations being honored have proven themselves to be the top performers in Compatibility, Capabilities, Expertise, Quality, Reliability, and Phase IV. We applaud these companies for their hard work in meeting the needs and expectations of their pharma and biotech clients.”

To learn about Worldwide’s uncommon approach to partnering with sponsor customers, please visit Worldwide.com.

About Worldwide Clinical Trials

Worldwide Clinical Trials employs more than 1,700 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia, and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services.

With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.

For more information, visit http://www.worldwide.com.

Contacts

Worldwide Clinical Trials

Lindsey Johnson

[email protected]